Better Sepsis Management Rather Than Fluoroquinolone Prophylaxis for Patients With Cancer-Related Immunosuppression-Reference-Cited by-同舟云学术

Better Sepsis Management Rather Than Fluoroquinolone Prophylaxis for Patients With Cancer-Related Immunosuppression

Published:2019-05-01 Issue:13 Volume:37 Page:1139-1140
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Slavin Monica A.¹,Worth Leon J.¹,Seymour John F.¹,Thursky Karin A.¹

Affiliation:

1. Monica A. Slavin, MD, Peter MacCallum Cancer Centre, and The National Centre for Infections in Cancer (NCIC), Melbourne, VIC, Australia; Leon J. Worth, PhD, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, and Doherty Institute, and The National Centre for Infections in Cancer (NCIC), Melbourne, VIC, Australia; John F. Seymour, PhD, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; and Karin A. Thursky, PhD, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, and...

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.18.01474

Reference9 articles.

1. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update

2. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

3. Implementation of a whole of hospital sepsis clinical pathway in a cancer hospital: impact on sepsis management, outcomes and costs

4. Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibacterial prophylaxis for neutropenic and high‐risk hematology patients—Do the benefits outweigh the risk?;Transplant Infectious Disease;2024-03-08

2. Current Practice of Antimicrobial Prophylaxis to Prevent Gram-Negative Bacterial Infection in High-Risk Haematology Patients: Results from an International Survey;2024

3. Fluoroquinolone prophylaxis in patients with neutropenia at high risk of serious infections: Exploring pros and cons;Transplant Infectious Disease;2023-09-25

4. Review: Levofloxacin Prophylaxis in Pediatric Oncology Patients;Current Treatment Options in Pediatrics;2022-06-29

5. Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome Structure;Transplantation and Cellular Therapy;2021-12